Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
WKS | Ann: Appendix 7 - Notice of Dividend | 14/02/19 | 0 | 131 | |||
|
|||||||
WKS | Ann: Condensed Half-year Financial Report | 14/02/19 | 0 | 114 | |||
|
|||||||
WKS | Ann: Half-year Investor Presentation - Supplementary Information | 08/02/19 | 0 | 104 | |||
|
|||||||
WKS | Ann: Half Yearly Report and Accounts | 07/02/19 | 0 | 146 | |||
|
|||||||
WKS | Ann: NSW Government orders 17 more Waratah trains | 07/02/19 | 0 | 98 | |||
|
|||||||
WKS | Ann: Downer JV awarded Parramatta Light Rail contract | 20/12/18 | 0 | 160 | |||
|
|||||||
WKS | Ann: Initial Disclosure Interest - Evan Charles Jensen | 14/12/18 | 0 | 186 | |||
|
|||||||
WKS | Ann: Initial Disclosure Notice - Michael James Ferguson | 14/12/18 | 0 | 181 | |||
|
See All Discussions